Sector stocks

Healthcare Stocks on NASDAQ

Compare NASDAQ-listed Healthcare stocks by fair value, valuation, financial health, profitability, risk, and market outlook.

Exicure Inc (XCUR)
Fair Value43.1% Upside Undervalued Market Cap5.827 M P/E— Yield0.0% HealthFair
  NASDAQ
Femasys Inc (FEMY)
Fair Value36.8% Upside Undervalued Market Cap10.971 M P/E— Yield0.0% HealthWeak
  NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value22.0% Upside Undervalued Analyst118.2% Upside Market Cap113.1 M P/E— Yield0.0% HealthFair
  NASDAQ
Fulcrum Therapeutics Inc (FULC)
Fair Value32.0% Upside Undervalued Analyst-0.4% Downside Market Cap280.8 M P/E— Yield0.0% HealthFair
  NASDAQ
Gain Therapeutics Inc (GANX)
Fair Value52.1% Upside Bargain Analyst650.0% Upside Market Cap41.915 M P/E— Yield0.0% HealthWeak
  NASDAQ
GeneDx Holdings Corp (WGS)
Fair Value-12.8% Downside Fair Analyst45.3% Upside Market Cap1.919 B P/E— Yield0.0% HealthGood
  NASDAQ
GH Research PLC (GHRS)
Fair Value-5.1% Downside Fair Analyst132.6% Upside Market Cap1.266 B P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Goodrx Holdings Inc (GDRX)
Fair Value49.6% Upside Undervalued Analyst13.2% Upside Market Cap1.191 B P/E73.3x Yield0.0% HealthGreat
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Gossamer Bio Inc (GOSS)
Fair Value39.7% Upside Undervalued Analyst912.7% Upside Market Cap57.616 M P/E— Yield0.0% HealthWeak
  NASDAQ
Greenwich Lifesciences Inc (GLSI)
Fair Value-7.1% Downside Fair Analyst289.1% Upside Market Cap215 M P/E— Yield0.0% HealthWeak
  NASDAQ
GRI Bio Inc (GRI)
Fair Value26.5% Upside Undervalued Market Cap3.388 M P/E— Yield0.0% HealthFair
  NASDAQ
Guardant Health Inc (GH)
Fair Value-25.2% Downside Overvalued Analyst31.8% Upside Market Cap20.59 B P/E— Yield0.0% HealthGood
  NASDAQ
Harmony Biosciences Holdings (HRMY)
Fair Value53.3% Upside Bargain Analyst48.1% Upside Market Cap1.907 B P/E10.7x Yield0.0% HealthGreat
  NASDAQ
HCW Biologics Inc (HCWB)
Fair Value46.2% Upside Undervalued Market Cap2.326 M P/E— Yield0.0% HealthFair
  NASDAQ
Health Catalyst Inc (HCAT)
Fair Value22.4% Upside Undervalued Analyst17.8% Upside Market Cap112.9 M P/E— Yield0.0% HealthGood
  NASDAQ
High Tide Inc (HITI)
Fair Value21.6% Upside Undervalued Analyst77.4% Upside Market Cap235.4 M P/E— Yield0.0% HealthGood
  NASDAQ
Humacyte Inc (HUMA)
Fair Value60.4% Upside Bargain Analyst310.4% Upside Market Cap109.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Hyperfine Inc (HYPR)
Fair Value40.3% Upside Undervalued Analyst195.6% Upside Market Cap72.686 M P/E— Yield0.0% HealthFair
  NASDAQ
I Mab (NBP)
Fair Value95.3% Upside Bargain Analyst854.5% Upside Market Cap105.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value5.6% Upside Fair Analyst68.2% Upside Market Cap2.964 B P/E— Yield0.0% HealthFair
  NASDAQ
IM Cannabis Corp (IMCC)
Fair Value71.2% Upside Bargain Market Cap977.622 K P/E— Yield0.0% HealthWeak
  NASDAQ
ImageneBio Inc (IMA)
Fair Value16.4% Upside Fair Analyst332.2% Upside Market Cap47.279 M P/E— Yield0.0% HealthFair
  NASDAQ
Immatics NV (IMTX)
Fair Value-2.5% Downside Fair Analyst165.4% Upside Market Cap844.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Immuneering Corp (IMRX)
Fair Value60.5% Upside Bargain Analyst404.5% Upside Market Cap218.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value23.7% Upside Undervalued Analyst120.9% Upside Market Cap1.463 B P/E— Yield0.0% HealthFair
  NASDAQ
Immunome Inc (IMNM)
Fair Value8.1% Upside Fair Analyst97.3% Upside Market Cap2.113 B P/E— Yield0.0% HealthFair
  NASDAQ
Immunovant Inc (IMVT)
Fair Value-3.7% Downside Fair Analyst72.2% Upside Market Cap5.864 B P/E— Yield0.0% HealthFair
  NASDAQ
In8bio Inc (INAB)
Fair Value52.6% Upside Bargain Analyst743.4% Upside Market Cap8.182 M P/E— Yield0.0% HealthFair
  NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value1.9% Upside Fair Analyst285.4% Upside Market Cap262.2 M P/E— Yield0.0% HealthFair
  NASDAQ
InMed Pharmaceuticals Inc (INM)
Fair Value-10.3% Downside Fair Market Cap8.777 M P/E— Yield0.0% HealthFair
  NASDAQ
InMode Ltd (INMD)
Fair Value49.7% Upside Undervalued Analyst20.6% Upside Market Cap770.2 M P/E9.9x Yield0.0% HealthGreat
  NASDAQ
INmune Bio Inc (INMB)
Fair Value23.7% Upside Undervalued Analyst493.2% Upside Market Cap36.136 M P/E— Yield0.0% HealthWeak
  NASDAQ
Innate Pharma SA (IPHA)
Fair Value11.4% Upside Fair Analyst376.2% Upside Market Cap131.7 M P/E— Yield0.0% HealthWeak
  NASDAQ
InnovAge Holding Corp (INNV)
Fair Value-4.2% Downside Fair Analyst32.0% Upside Market Cap1.24 B P/E137.9x Yield0.0% HealthGreat
  NASDAQ Featured in Low-Float Small-Cap Momentum Stocks High-Growth Small-Cap Stocks
Instil Bio Inc (TIL)
Fair Value30.5% Upside Undervalued Analyst0.1% Upside Market Cap47.406 M P/E— Yield0.0% HealthGood
  NASDAQ
Intelligent Bio Solutions Inc (INBS)
Fair Value39.1% Upside Undervalued Analyst581.8% Upside Market Cap5.328 M P/E— Yield0.0% HealthFair
  NASDAQ
Inventiva Sa (IVA)
Fair Value-30.1% Downside Overvalued Analyst318.7% Upside Market Cap890.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Invivyd Inc (IVVD)
Fair Value20.3% Upside Undervalued Market Cap172.4 M P/E— Yield0.0% HealthGood
  NASDAQ
INVO Fertility Inc (IVF)
Fair Value20.2% Upside Undervalued Market Cap2.421 M P/E— Yield0.0% HealthFair
  NASDAQ
ISpecimen Inc (ISPC)
Fair Value27.6% Upside Undervalued Market Cap2.035 M P/E— Yield0.0% HealthWeak
  NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-7.7% Downside Fair Analyst255.5% Upside Market Cap896.7 M P/E— Yield0.0% HealthGood
  NASDAQ
Janux Therapeutics Inc (JANX)
Fair Value28.5% Upside Undervalued Analyst99.7% Upside Market Cap981.9 M P/E— Yield0.0% HealthGood
  NASDAQ
Jasper Therapeutics Inc (JSPR)
Market Cap15.612 M P/E— Yield0.0% HealthWeak
  NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value2.4% Upside Fair Analyst648.6% Upside Market Cap56.18 M P/E— Yield0.0% HealthWeak
  NASDAQ
Keros Therapeutics Inc (KROS)
Fair Value53.5% Upside Bargain Analyst109.9% Upside Market Cap187.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-36.9% Downside Overvalued Analyst33.7% Upside Market Cap5.709 B P/E— Yield0.0% HealthFair
  NASDAQ
Korro Bio Inc (KRRO)
Fair Value-11.7% Downside Fair Analyst37.1% Upside Market Cap216.9 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
KORU Medical Systems Inc (KRMD)
Fair Value7.9% Upside Fair Analyst106.3% Upside Market Cap139.9 M P/E— Yield0.0% HealthGood
  NASDAQ
Kymera Therapeutics Inc (KYMR)
Fair Value-27.8% Downside Overvalued Analyst12.8% Upside Market Cap10.938 B P/E— Yield0.0% HealthFair
  NASDAQ
Lantern Pharma Inc (LTRN)
Fair Value40.2% Upside Undervalued Market Cap6.801 M P/E— Yield0.0% HealthWeak
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.